Xtant Medical Holdings Inc (XTNT) — Capital Reinvestment Ratio

Latest as of December 2025: 0.07x

Xtant Medical Holdings Inc (XTNT) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.38 Million) in capital expenditures ($395.00K). See XTNT equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

$5.38 Million
USD

Capital Expenditures

$395.00K
USD

Data as of

Dec 2025
Most recent filing

Xtant Medical Holdings Inc Capital Reinvestment Ratio (2018–2025)

This chart tracks Xtant Medical Holdings Inc's Capital Reinvestment Ratio across 3 annual periods. Check XTNT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Xtant Medical Holdings Inc (2018–2025)

Year-by-year Capital Reinvestment Ratio for Xtant Medical Holdings Inc from 2018 to 2025. For live market cap and broader valuation context, see Xtant Medical Holdings Inc market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.19x $12.55 Million $2.38 Million ▼ -96.1%
2021 4.82x $439.00K $2.12 Million ▲ +835.8%
2018 0.51x $1.21 Million $624.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow